
    
      Phase IIIb. Early Psoriatic Arthritis. Investigator initiated, double-blind, randomized,
      placebo-controlled, two-armed, parallel-group, single centre trial.

      The Primary Objective is to assess whether the combination of golimumab with methotrexate and
      steroids is superior to standard care (MTX monotherapy plus steroids) in reducing clinical
      disease activity in patients with early, treatment na√Øve PsA.
    
  